EMEA-002075-PIP01-16-M01

Key facts

Active substance
Lefamulin
Therapeutic area
Infectious diseases
Decision number
P/0066/2019
PIP number
EMEA-002075-PIP01-16-M01
Pharmaceutical form(s)
  • Concentrate for solution for infusion
  • Coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of community-acquired pneumonia
Route(s) of administration
  • Intravenous use
  • Oral use
Contact for public enquiries
Nabriva Therapeutics Ireland Designated Activity Company

E-mail: gary.sender@nabriva.com
Tel. +1 6108 136425

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating
1 rating